Plain-English translation of NCT07692438 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether Taiwan green propolis—a natural supplement made from bee resin—can help improve cholesterol levels and reduce body fat in people with metabolic dysfunction-associated steatotic liver disease (a condition where fat builds up in the liver). Half of the participants will receive the actual propolis supplement, and half will receive a placebo (an inactive pill that looks identical) for 12 weeks. Researchers will measure changes in blood lipids, body composition, liver function, and other health markers to see if the treatment works.
Fatty liver disease is becoming increasingly common and is often linked to obesity, high cholesterol, and metabolic problems, but there are limited treatment options beyond lifestyle changes. This medication is being tested because early research suggests it may have natural anti-inflammatory and metabolism-boosting properties that could help improve cholesterol and reduce fat in the liver.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital for a baseline assessment that includes measurements of your body, blood tests, liver ultrasound, and questionnaires. Then you will take 4 capsules per day (2 before breakfast and 2 before dinner) for 12 weeks—either the actual propolis supplement or a matching placebo. You'll return for check-ins at weeks 4, 8, 12, and 14, where you'll have repeat blood tests and body measurements to track any changes. The entire study lasts about 14 weeks from start to finish.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
Taiwan